Prognostic Value of Coronary Vascular Endothelial Dysfunction
Top Cited Papers
- 6 August 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation
- Vol. 106 (6), 653-658
- https://doi.org/10.1161/01.cir.0000025404.78001.d8
Abstract
Background— Whether patients at increased risk can be identified from a relatively low-risk population by coronary vascular function testing remains unknown. We investigated the relationship betwee...Keywords
This publication has 14 references indexed in Scilit:
- Contribution of bradykinin receptor dysfunction to abnormal coronary vasomotion in humansJournal of the American College of Cardiology, 2000
- Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk PatientsNew England Journal of Medicine, 2000
- Inflammatory Cytokines and Oxidized Low Density Lipoproteins Increase Endothelial Cell Expression of Membrane Type 1-Matrix MetalloproteinaseJournal of Biological Chemistry, 1999
- Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol LevelsNew England Journal of Medicine, 1998
- Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory DiseasesNew England Journal of Medicine, 1997
- Nitric Oxide Activity in the Atherosclerotic Human Coronary CirculationJournal of the American College of Cardiology, 1997
- Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. Implications for atherosclerotic plaque stability.Journal of Clinical Investigation, 1996
- Nitric oxide activity in the human coronary circulation. Impact of risk factors for coronary atherosclerosis.Journal of Clinical Investigation, 1995
- Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques.Journal of Clinical Investigation, 1994
- Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patientsBMJ, 1994